News

Two babies in Oregon became ill with lead poisoning after eating baby food from Target that had been previously recalled, ...
The FDA signed off on KalVista Pharmaceuticals' emergency treatment for swelling attacks associated with a rare, genetic disease.
New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...
Outset Medical's Tablo is gaining momentum in hospitals, supported by recurring revenues and solid fundamentals. Learn more ...
San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to ...
Ekterly comes in the form of a 300 mg tablet. The recommended dosage is 600 mg split into two doses taken at the earliest sign of an attack, according to the prescribing information. Additional ...
Sirtex Medical announced that the FDA has approved the company’s SIR-Spheres yttrium-90 (Y90) resin microspheres for the trea ...
A new clinical trial using a botanical psilocybin drug to treat co-occurring PTSD and alcohol use disorder (AUD) in veterans ...
The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell ...
ACHV's cytisinicline shows best-in-class efficacy and safety for smoking cessation. Click here to find out why ACHV stock is ...